The Board Meeting to be held on 01/08/2026 has been revised to 31/07/2026 The Board Meeting to be held on 01/08/2026 has been revised to 31/07/2026

Date: 29th July, 2026 The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001 Mumbai - 400 051. Security Code: 532815 Symbol: SMSPHARMA Dear Sir/Madam, Sub: Rescheduling of Board meeting from 1st August, 2026 to 31st July, 2026. Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 With reference to our earlier intimation dated 25th July, 2026 regarding the meeting of the Board of Directors of the Company scheduled to be held Saturday, 1st August, 2026, inter alia to consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the first quarter ended on 30th June, 2026. We hereby inform you that, due to unavoidable administrative exigencies, the meeting of the Board of Directors has been preponed and will now be held on Friday, 31st July 2026, instead of Saturday, 01st August 2026, to transact the same business as intimated earlier. In accordance with the Company’s Code of Conduct for Prevention of Insider Trading, pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has already intimated its designated persons including directors regarding the closure of the ‘Trading Window’ for trading in the Company's equity shares from 01st July, 2026, it will remain closed up to 02nd August, 2026 (both days inclusive) and shall be re-opened on 03rd August, 2026. We request to kindly take note of the same. Thanking you Yours faithfully For SMS Pharmaceuticals Limited Thirumalesh Tumma Company Secretary & Compliance Officer